Omenn syndrome is an autosomal recessive disorder of the immune system, characterized by severe combined immunodeficiency (SCID) on the one hand, and increased autoimmunity on the other. The condition is characterized by failure to thrive, alopecia, desquamation, erythroderma, hepatosplenomegaly, and lymphadenopathy, along with elevated T lymphocyte and IgE levels, and defective B and T cell function. These clinical presentations are succeeded by serious, life-threatening bacterial, viral and/or fungal infections, and chronic diarrhea. Age of presentation is very early, and usually does not exceed six months.
For clinicians, the most distinctive and early diagnostic symptom of the disease is exfoliative erythroderma. Differential diagnoses to be considered include collodion baby, dermatitis, psoriasis, ichthyosis, maternal or fetal graft versus host syndrome, Netherton syndrome, IgA deficiency, and other SCIDs. Flow cytometric analysis of the lymphocytes and immunoglobulin levels gives a clearer indication. Pneumonia and septic shock are the usual causes of death in this condition. The only reliable cure for the condition is bone marrow transplantation. Although there is a recognized risk of Graft Versus Host Disease with this procedure, a fairly good rate of Omenn syndrome patients subjected to BMT have fully recovered.